Loading...

Valneva SE

INRLF•PNK
Healthcare
Biotechnology
$3.15
$0.00(0.00%)
U.S. Market opens in 0h 55m

Valneva SE (INRLF) Stock Overview

Explore Valneva SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap542.1M
P/E Ratio-4.06
EPS (TTM)$-0.80
ROE-0.75%
Fundamental Analysis

AI Price Forecasts

1 Month$5.03
3 Months$6.24
1 Year Target$4.52

INRLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Valneva SE (INRLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.06 and a market capitalization of 542.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-10.00%
3-Month Change
-30.77%
6-Month Change
-31.52%
Year-to-Date (YTD) Change
-25.00%
1-Year Change
11.70%
3-Year Change
-33.68%
5-Year Change
-80.40%
All-Time (Max) Change
-89.32%

Contact Information

https://valneva.com
33 2 28 07 37 10
6 rue Alain Bombard, Saint-Herblain, NaN, 44800

Company Facts

713 Employees
IPO DateApr 23, 2010
CountryFR
Actively Trading

Frequently Asked Questions